Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Drug Manufacturers - Major Cannabis Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp
Bullboard Posts
User Avatar Image
(30)
•••
Comment by DonnieSilveron Nov 21, 2016 5:31pm
165 Views
Post# 25492157

RE:RE:RE:I want in so bad. Just can't until $7

RE:RE:RE:I want in so bad. Just can't until $7
kingbear wrote: lmao well below $4? what a moron. I don't even own shares in this company and I think that's one of the dumbest comments I've read on here in a while. People seem to forget the rapidly increasing revenues from medical mj.
PsychicTrader wrote: $15 cgc days are gone for now. For short term, Look for entry around $6.5 or less and sell in $8.3 to $ 8.6 range. Careful as cgc can drop well below $4 by end of december. Legal MJ is not hitting stores until late 2018 or early 2019. Only then it will have the chance to find a new floor at $15. Happy trading!
Mick1Edwards wrote: That's my comfort zone. We better have another strong market tomorrow or who knows where this could end up. On the other hand positive/fast track legislation could vault this stock to $15 before you can even get logged into your trading account. 

 



I couldn't agree with psychictrader more.  Good post man.
 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities